Home Tags Alzheimer’s Disease

Alzheimer’s Disease Related Content

Alzheimer’s Disease is the most common cause of dementia. Dementia describing a specific set of symptoms such as memory loss, difficulties with problem-solving, language or simply thinking. As the disease progresses, proteins build up in the brain to form structures called ‘plaques’. Eventually there is a break between the nerve cells resulting the death of the cells and a loss of brain tissue. ending in a lack of motor skills. Although progression can vary, typically after diagnosis life expectancy is around three to nine years. Fewer than 3% of people live more than fourteen years.

Management

medications, psychological intervention and care-giving are all available to AD patients. there are currently 5 different medications on offer for AD each have different results and side affects.

nitric oxide

Chemistry analysis: Microfluidic detection of intracellular nitric oxide levels

Jay Sibbitts, Prof Dr Stefan H. Bossmann and Prof Dr Christopher T. Culbertson, from Kansas State University, Department of Chemistry in the U.S., underline microfluidic detection of intracellular nitric oxide levels.
alzheimer’s and dementia funding

Alzheimer’s and dementia funding rises in the U.S.

Rachel Conant, Vice President Federal Affairs, Alzheimer’s Association and Alzheimer’s Impact Movement, provides us with an update on Alzheimer’s and dementia funding rises in the United States.
Alzheimer’s disease progression

Graph theory in the study of Alzheimer’s disease progression

María J. Peláez1, Prashant Dogra1, Zhihui Wang1, Vittorio Cristini1 1Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX 77030, USA.
difference between dementia and alzheimer’s

Understanding the difference between Dementia and Alzheimer’s

Ella Hendrix, Writer, takes it back to basics and explains the difference between Dementia and Alzheimer's disease
neurodegenerative diseases, protein

A brief overview of advances in neurodegenerative diseases

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, provides an overview of Neurodegenerative Diseases.
vitamin b12

Vitamin B12 and brain health of older people

Here, Professor Timothy Kwok discusses the impact of vitamin B12 on the brain health of older people.
data linkage, health longevity

Data linkage and sharing for healthy longevity: A global challenge

Data linkage and sharing for healthy longevity together present a global challenge, in the view of Prof Makoto Suematsu, Japan Agency for Medical Research and Development and Rihana Diabo at the World Economic Forum.
link with dementia, hearing loss

Hearing loss and the link with dementia

If we address hearing loss, can we really decrease our risk of developing dementia? Mark Atkinson, Chief Executive Action of Hearing Loss investigates.

Intramembrane proteases in neurodegenerative diseases

Prof Dr Regina Fluhrer, from the University of Augsburg, explains how intramembrane proteases have been implicated in the emergence of neurodegenerative diseases.
health-data programme

New health-data programme to detect diseases early

Diseases could be detected even before people experience symptoms, thanks to a pioneering new health-data programme as part of the government’s modern Industrial Strategy.
early alzheimers disease, virtual reality

Virtual reality can spot problems in early Alzheimer’s disease

The University of Cambridge found that virtual reality (VR) can identify early Alzheimer’s disease better than ‘gold standard’ cognitive tests currently in use.
with dementia

Up to 2 million will live with dementia by 2050

According to the Alzheimer Society 850,000 people in the UK have dementia but with 1 in 6 people over the age of 80 living with dementia, this is predicted to rise to over 2 million by 2050 as the population ages.
America Analysis

North America Analysis – April 2019

Welcome to the April 2019 edition of North America Analysis. One of the highlights in this issue is the special focus we have on neurodegenerative diseases, which includes comment from Jeffrey Borenstein, of the Brain & Behavior Research Foundation (BBRF).
Alzheimer's disease research

Supporting vital Alzheimer’s disease research in the U.S and beyond

The work of the National Institute on Aging (NIA) is placed into focus here, with examples of how they are supporting vital Alzheimer’s disease research in the U.S and further afield.
dementia and alzheimer's

Defining dementia and Alzheimer’s in the 21st century

Paul Edwards, Director of Clinical Services at Dementia UK, explores what dementia actually means in the 21st century, including the all-important differences between dementia and Alzheimer’s.
living with Alzheimer's, Federal Affairs Alzheimer's association

Bold action by Congress delivers victory to millions living with Alzheimer’s

Rachel Conant, Senior Director, Federal Affairs, Alzheimer’s Association explains how bold action by the U.S. Congress delivers victory to the millions of people living with Alzheimer's.
Alzheimer's brain, Alzheimer's disease research

Scientists reveal largest ever map of human Alzheimer’s brain

On the 4th February 2019, a scientific breakthrough for the future of Alzheimer's brain reserach has been published - read on to explore the developments.
dementia research

Turning up the volume of the patient voice in dementia research

Dr James Pickett, Head of Research at Alzheimer’s Society presents the case for turning up the volume of the patient voice when it comes.
neurodegenerative disorders

Treatment and diagnosis of neurodegenerative disorders

Andrea Varrone studies the importance of molecular imaging to provide personalised medicine and improve care for patients with neurodegenerative disorders
neurodegenerative diseases

Tackling neurodegenerative diseases including Alzheimer’s

The work of the EU Joint Programme – Neurodegenerative Disease Research (JPND) which aims to tackle the challenge of these diseases, in particular, Alzheimer’s, is discussed here

Follow Open Access Government